medroxyprogesterone acetate and Signs and Symptoms

Topics: Amenorrhea; Asia; Asia, Eastern; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Developing Countries; Disease; Evaluation Studies as Topic; Family Planning Services; Hemorrhage; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Metrorrhagia; Patient Acceptance of Health Care; Signs and Symptoms

Topics: Amenorrhea; Asia; Asia, Eastern; Biology; Blood; Blood Coagulation; Carbohydrates; China; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Developing Countries; Disease; Endocrine System; Endometrium; Family Planning Services; Fibrinolysis; Genitalia; Genitalia, Female; Glucose; Hemorrhage; Hormones; Injections; International Agencies; Lipids; Medroxyprogesterone Acetate; Megestrol Acetate; Menstruation Disturbances; Metabolism; Norethindrone; Organizations; Ovulation; Patient Acceptance of Health Care; Physiology; Progesterone; Progestins; Reproduction; Research; Signs and Symptoms; United Nations; Urogenital System; Uterus; World Health Organization

Topics: Age Factors; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Evaluation Studies as Topic; Family Planning Services; Genitalia; Genitalia, Female; Hemorrhage; Histology; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Parity; Physiology; Research; Signs and Symptoms; Urogenital System; Uterus

Topics: Age Factors; Amenorrhea; Americas; Appetite; Biology; Body Weight; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Data Collection; Demography; Developed Countries; Disease; Drug Interactions; Family Planning Services; Hypersensitivity; Interviews as Topic; Medroxyprogesterone Acetate; Menstruation Disturbances; North America; Pharmaceutical Preparations; Physiology; Population; Population Characteristics; Progesterone Congeners; Research; Signs and Symptoms; Therapeutics; United States

Topics: Coitus Interruptus; Condoms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Disease; Family Planning Services; Intrauterine Devices; Medroxyprogesterone Acetate; Menopause; Progesterone Congeners; Reproduction; Signs and Symptoms; Spermatocidal Agents; Sterilization, Reproductive

Topics: Ambulatory Care Facilities; Biology; Body Weight; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Counseling; Disease; Economics; Family Planning Services; Health Planning; Health Services Needs and Demand; Hemorrhage; Injections; Medroxyprogesterone Acetate; Metrorrhagia; Organization and Administration; Physiology; Signs and Symptoms

Topics: Blood Coagulation; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Digestive System; Disease; Embolism; Ethinyl Estradiol; Family Planning Services; Hemorrhage; Injections; Lynestrenol; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation; Mestranol; Metrorrhagia; Nausea; Norethindrone; Norethynodrel; Pseudopregnancy; Reproduction; Signs and Symptoms; Thromboembolism; Vascular Diseases

Topics: Amenorrhea; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Family Planning Services; Hemorrhage; Infertility; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Metrorrhagia; Research; Signs and Symptoms

Topics: Amenorrhea; Appetite; Central Nervous System; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Digestive System; Disease; Evaluation Studies as Topic; Family Planning Services; Hemorrhage; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Metrorrhagia; Research; Signs and Symptoms

Topics: Amenorrhea; Americas; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; England; Europe; Evaluation Studies as Topic; Family Planning Services; Hemorrhage; Injections; Legislation as Topic; Medroxyprogesterone Acetate; Menstruation Disturbances; Metrorrhagia; Neoplasms; North America; Signs and Symptoms; United Kingdom; United States

Topics: Asia; Birth Intervals; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Data Collection; Developing Countries; Diagnosis; Disease; Endoscopy; Family Planning Services; Headache; Health; Health Knowledge, Attitudes, Practice; Hemorrhage; Laparoscopy; Medroxyprogesterone Acetate; Nausea; Nepal; Nutritional Physiological Phenomena; Physical Examination; Research; Sampling Studies; Signs and Symptoms; Sterilization, Reproductive; Surveys and Questionnaires; Vasectomy

Topics: Americas; Consumer Product Safety; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Delivery of Health Care; Developed Countries; Disease; Drug Prescriptions; Family Planning Services; Health; Health Personnel; Health Planning; Hemorrhage; Informed Consent; Legislation as Topic; Medroxyprogesterone Acetate; North America; Organization and Administration; Physicians; Signs and Symptoms; United States

Topics: Adolescent; Age Factors; Ambulatory Care Facilities; Americas; Appetite; Behavior; Biology; Body Weight; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Counseling; Demography; Developed Countries; Diet; Disease; Family Planning Services; Health; Health Planning; Medroxyprogesterone Acetate; North America; Nutritional Physiological Phenomena; Organization and Administration; Physiology; Population; Population Characteristics; Risk-Taking; Sexual Behavior; Signs and Symptoms; United States